- Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients.
- Alzahrani OR, Mir R, Alatwi HE, Hawsawi YM, Alharbi AA, Alessa AH, Albalawi ES, Elfaki I, Alalawi Y, Moharam L, El-Ghaiesh SH.
- Cancers (Basel). 2023 Feb 17;15(4):1281. doi: 10.3390/cancers15041281.
- Das familiäre Pankreaskarzinomsyndrom [Familial pancreatic cancer syndrome].
- Seifert L, Weitz J.
- Chirurgie (Heidelb). 2023 Feb 17. German. doi: 10.1007/s00104-023-01819-8. Epub ahead of print.
- PMID: 36799964
- PubMed abstract
- Source abstract
- Review. [Article in German]
- Association of FANCM Mutations with Familial and Early-Onset Breast Cancer Risk in a South American Population.
- Morales-Pison S, Morales-González S, Fernandez-Ramires R, Tapia JC, Maldonado E, Calaf GM, Jara L.
- Int J Mol Sci. 2023 Feb 17;24(4):4041. doi: 10.3390/ijms24044041.
- Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing.
- Dixon K, Shen Y, O'Neill K, Mungall KL, Chan S, Bilobram S, Zhang W, Bezeau M, Sharma A, Fok A, Mungall AJ, Moore R, Bosdet I, Thibodeau ML, Sun S, Yip S, Schrader KA, Jones SJM.
- Eur J Hum Genet. 2023 Feb 16. doi: 10.1038/s41431-023-01284-1. Epub ahead of print.
- PMID: 36797466
- PubMed abstract
- Updates in Gynecologic Care for Individuals with Lynch Syndrome.
- Underkofler KA, Ring K.
- Front Oncol. 2023 Feb 16;13:1127683. doi: 10.3389/fonc.2023.1127683.
- Review
- Free Full Text
- Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
- Fizazi K, Piulats JM, Reaume MN, Ostler P, McDermott R, Gingerich JR, Pintus E, Sridhar SS, Bambury RM, Emmenegger U, Lindberg H, Morris D, Nolè F, Staffurth J, Redfern C, Sáez MI, Abida W, Daugaard G, Heidenreich A, Krieger L, Sautois B, Loehr A, Despain D, Heyes CA, Watkins SP, Chowdhury S, Ryan CJ, Bryce AH; TRITON3 Investigators.
- N Engl J Med. 2023 Feb 16. doi: 10.1056/NEJMoa2214676. Epub ahead of print.
- PMID: 36795891
- PubMed abstract
- Source abstract
•• Identifier: NCT02975934: A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON3). (ClinicalTrials.gov . Accessed 2023 Feb 16.)
•• Research news: Rucaparib Bests Physician's Choice for BRCA+ mCRPC. (OncLive)
- Diagnosis, Management, and Surveillance for Patients with PALB2, CHEK2, and ATM Gene Mutations.
- Fencer MG, Krupa KA, Bleich GC, Grumet S, Eladoumikdachi FG, Kumar S, Kowzun MJ, Potdevin LB.
- Clin Breast Cancer. 2023 Feb 15:S1526-8209(23)00034-4. doi: 10.1016/j.clbc.2023.02.004. Epub ahead of print.